Respiratory virus activity is high and rising across the United States, CDC data shows

https://www.yahoo.com/lifestyle/respiratory-virus-activity-high-rising-192815114.html

As seasonal virus activity surges across the United States, experts stress the importance of preventive measures – such as masking and vaccination – and the value of treatment for those who do get sick.

Tens of thousands of people have been admitted to hospitals for respiratory illness each week this season. During the week ending December 23, there were more than 29,000 patients admitted with Covid-19, about 15,000 admitted with the flu and thousands more with respiratory syncytial virus, or RSV, according to data from the US Centers for Disease Control and Prevention.

Nationally, Covid-19 levels in wastewater, a leading measure of viral transmission, are very high – higher than they were at this time last year in every region, CDC data shows. Weekly emergency department visits rose 12%, and hospitalizations jumped about 17% in the most recent week.

And while Covid-19 remains the leading driver of respiratory virus hospitalizations, flu activity is rising rapidly. The CDC estimates that there have been more than 7 million illnesses, 73,000 hospitalizations and 4,500 deaths related to the flu this season, and multiple indicators are high and rising.

RSV activity is showing signs of slowing in some parts of the US, but many measures, including hospitalization rates, remain elevated. Overall, young children and older adults are most affected.

“It’s a wave of winter respiratory pathogens, especially respiratory viruses. So it’s Covid, it’s flu, and we can’t diminish the importance of RSV,” said Dr. Peter Hotez, dean of the National School of Tropical Medicine at the Baylor College of Medicine. “So it’s a triple threat, and arguably a fourth threat because we also have pneumococcal pneumonia, which complicates a lot of these virus infections.”

Respiratory virus activity has been on the rise for weeks. Now, flu-like activity is high or very high in two-thirds of the United States, including California, New York City and Washington, as well as throughout the South and Northeast, according to the CDC.

“Remember, all of these numbers are before people got together for the holidays,” Hotez said. “So don’t be disappointed or surprised that we even see a bigger bump as we head into January.”

Vaccines can help prevent severe illness and death, but uptake remains low this season – despite a historic first, with vaccines available to protect against each of the three major viruses. Just 19% of adults and 8% of children have gotten the latest Covid-19 vaccine, and 17% of adults 60 and older have gotten the new RSV vaccine, CDC data shows. Less than half of adults and children have gotten the flu vaccine this season.

“We have, as a population, underutilized both influenza and the updated Covid vaccines, unfortunately,” said Dr. William Schaffner, an infectious disease expert at Vanderbilt University. “But it’s not too late to get vaccinated, because these viruses are going to be around for a while yet.”

According to the CDC, hospital bed capacity remains “stable” nationally, including within intensive care units. But with high levels of respiratory viruses, hospitals in at least five states are returning to requiring masks.

Mass General Brigham spokesman Timothy Sullivan said it will require masking for health-care staff who interact directly with patients starting Tuesday, and patients and visitors will be “strongly encouraged to wear a facility-issued mask.”

In Wisconsin, UW Health and UnityPoint Health – Meriter have expanded mask policies to cover more people. UW requires all staff, patients and visitors to wear a mask for patient interactions in clinic settings, including waiting areas and exam rooms.

UnityPoint Health – Meriter says masks continue to be required for team members and visitors in patient rooms.

Bellevue, a public hospital in New York City, said on social media last week that it had reinstated its mandatory masking policy due to an uptick in respiratory illnesses.

In Pennsylvania, the University of Pittsburgh Medical Center has required everyone to wear a mask when entering or inside since December 20. The systemwide masking policies were adjusted to “address the increase of respiratory virus cases” but may change when there is a “marked decrease in respiratory health cases,” according to the health care system.

An order posted last week by the Los Angeles County Health Officer requires all health-care personnel and visitors to mask while in contact with patients or in patient-care areas, based on the CDC’s categorization of Covid-19 hospital admission levels.

During the week ending December 23, more than 230 US counties were considered to have “high” levels of Covid-19 hospital admissions, defined by the CDC by at least 20 new hospital admissions for every 100,000 people. Nearly a thousand other counties, about a third of the country, have “medium” Covid-19 hospital admission levels, with at least 10 admissions for every 100,000 people.

Vaccines and masks can help reduce the risk of severe illness before getting sick, but treatments are also available to help prevent people from getting very sick if they do become infected.

Antiviral treatments for Covid-19, such as Paxlovid, and flu, such as Tamiflu, can be especially helpful for people who are more likely to get very sick, including people who are 50 or older and those with certain underlying conditions, such as a weakened immune system, heart disease, obesity, diabetes or chronic lung disease.

“If more people at higher risk for severe illness get treatment in a timely manner, we will save lives,” the CDC said in a recent blog post. But “not enough people are taking them.”

Seasonal respiratory virus activity can be hard to predict, but CDC forecasts suggest that hospitalization rates will continue at elevated levels for weeks and that this season, overall, will probably result in a similar number of hospitalizations as last season.

“One of the ways to help us all go into a happy new year is for us to be as protected as we can against these viruses,” Schaffner said.

“Of course, I continue to recommend vaccination, prudent use of the mask by high-risk people and, should you become sick, do not go to work and spread the virus further. Call your health care provider, because you may have some treatment available that will get you healthier sooner.”

I’m Glad I’m not a California Hospital or Practice Administrator…

On January 1st, 2024 #AB1076 and #SB699, two draconian noncompete laws go into effect. It could put many #employedphysicians in a new position to walk away from #employeeremorse.

AB1076 voids non-compete contracts and require the employer to give written notice by February 14th, 2024 that their contract is void.

Is this a good or bad thing? It depends.

If the contract offers more protections and less risk to the employed physician, and the contract is void – does that mean the whole contract is void? Or is the non-compete voidable?

But for the hospital administrator or practice administrator, we’re about to witness the golden handcuffs come off and administrators will have to compete to retain talent that could be lured away more easily than in the past. But the effect of the non-compete is far more worrisome for an administrator because of the following:

The physicians many freely and fairly compete against the former employer by calling upon, soliciting, accepting, engaging in, servicing or performing business with former patients, business connections, and prospective patients of their former employer.

It could also give rise to tumult in executive positions and management and high value employees like managed care and revenue cycle experts who may have signed noncompete contracts.

If the employer does not follow through with the written notice by February 14th, the action or failure to notify will be “deemed by the statute to be an act of unfair competition that could give rise to other private litigation that is provided for in SB699.

The second law, SB699, provides a right of private action, permitting the former employees subject to SB699 the right to sue for injunctive relief, recovery of actual damages, and attorneys fees. It also makes it a civil violation to enter into or enforce a noncompete agreement. It further applies to employees who were hired outside California but now work in or through a California office.

What else goes away?

Employed physicians can immediately go to work for a competitor and any notice requirement or waiting period (time and distance provisions) are eliminated by the laws. So an administrator could be receiving “adios” messages on January 2nd, and watch market share slip through their fingers like a sieve starting January 3rd.

And what about the appointment book? Typically, appointments are set months in advance, especially for surgeons – along with surgery bookings, surgery block times, and follow up visits.

Hospitals may be forced to reckon with ASCs where the surgeons could not book cases under their non-compete terms and conditions. They could up and move their cases as quickly as they can be credentialed and privileged and their PECOS and NPPES files updated and a new 855R acknowledged as received.

Will your key physicians, surgeons and APPs leave on short notice?

APPs such as PAs and NPs could also walk off and bottleneck appointment schedules, surgical assists, and many office-based procedures that were assigned to them. They could also walk to a new practice or a different hospitals and also freely and fairly compete against the former employer by calling upon, soliciting, accepting, engaging in, servicing or performing business with former patients, business connections, and prospective patients of their former employer.

Next, let’s talk about nurses and CRNAs. If they walk off and are lured away to a nearby ASC or hospital, or home health agency, that will disrupt many touchpoints of the current employer.

Consultants’ contracts are another matter to be reckoned with. In all my California (and other) contracts, contained within them are anti-poaching provisions that state that I may not offer employment to one of their managed care, revenue cycle, credentialing, or business development superstars. Poof! Gone!

The time to conduct a risk assessment is right now! But many of the people who would be assigned this assessment are on holiday vacation and won’t be back until after January 1st. But then again, they too could be lured away or poached.

What else will be affected?

Credentialing and privileging experts should be ready for an onslaught of applications that have to be processed right away. They will not only be hit with new applications, but also verification of past employment for the departing medical staff.

Billing and Collections staff will need to mount appeals and defenses of denied claims without easy access they formerly had with departing employed physicians.

Medical Records staff will need to get all signature and missing documentation cleared up without easy access they formerly had with departing employed physicians.

Managed Care Network Development experts at health plans and PPOs and TPAs will be recredentialing and amending Tax IDs on profiles of former employed physicians who stand up their own practice or become employed or affiliated with another hospital or group practice. This comes at an already hectic time where federal regulations require accurate network provider directories.

The health plans will need to act swiftly on these modifications because NCQA-accredited health plans must offer network adequacy and formerly employed physicians who depart one group but cannot bill for patient visits and surgeries until the contracting mess is cleared up does not fall under “force majeure” exceptions. If patients can’t get appointments within the stated NCQA time frames, the health plan is liable for network inadequacy. I see that as “leverage” because the physician leaving and going “someplace else” (on their own, to a new group or hospital) can push negotiations on a “who needs whom the most?” basis. Raising a fee schedule a few notches is a paltry concern when weight against loss of NCQA accreditation (the Holy Grail of employer requirements when purchasing health plan benefits from a HMO) and state regulator-imposed fines. All it takes to attract the attention of regulators and NCQA are a few plan member complaints that they could not get appointments timely.

Health plans who operate staff model and network model plans that employ physicians, PAs and NPs (e.g., Kaiser and others who employ the participating practitioners and own the brick and mortar clinics where they work) are in for risk of losing the medical staff to “other opportunities.” These employment arrangements are at a huge risk of disruption across the state.

Workers Compensation Clinics that dot the state of California and already have wait times measured in hours as well as Freestanding ERs and Freestanding Urgent Care Clinics could witness a mass exodus of practitioners that disrupt operations and make their walk in model inoperative and unsustainable in a matter of a week.

FQHCs that employ physicians, psychotherapists, nurse practitioners and physician assistants could find themselves inadequately staffed to continue their mission and operations. Could this lead to claims of patient abandonment? Failed Duty of Care? Who would be liable? The departing physician or their employer?

And then, there are people like me – consultants who help stand up new independent and group practices, build new brands, rebrand the physicians under their own professional brands, launch new service lines like regenerative medicine and robotics, cardiac and vascular service lines, analyze managed care agreements, physician, CRNA, psychotherapist, and APP employment agreements. There aren’t many consultants with expertise in these niches. There are even fewer who are trained as paralegals, and have practical experience as advisors or former hospital and group practice administrators (I’ve done both) who are freelancers. I expect I will become very much in demand because of the scarcity and the experience. I am one of very few experts who are internationally-published and peer-reviewed on employment contracts for physicians.

Medicare Advantage growth raises critical financial questions

https://www.healthcarefinancenews.com/news/medicare-advantage-growth-raises-critical-finance-questions?mkt_tok=NDIwLVlOQS0yOTIAAAGQUFhbkkHv384x6craLzqoe6oHg01nqFqx-KlDVb0BCDM6aiCHEBB94evVFaOwkkTkrcUXaAInnPvVDT1QkR_XHnBX1GXxENhSkCIDk4q75UM

In the coming year, more than half of Medicare’s 66 million beneficiaries may opt for private Medicare Advantage plans, a development likely to put further strain on an already overstretched healthcare system, according to a report in the New England Journal of Medicine.

The report, written by Gretchen Jacobson and David Blumenthal, raised several questions regarding the ascendancy of MA, its impact on care quality, cost considerations and the broader implications for the healthcare system.

Jacobson, a vice president at the Commonwealth Fund, and Blumenthal, previously the fund’s president, delve into the intricacies of MA, outlining its operational mechanisms, payment structures and performance relative to traditional Medicare.

WHY THIS MATTERS

Medicare Advantage, also known as Medicare Part C, is an alternative to traditional Medicare offered by private insurance companies.

It typically includes additional benefits such as prescription drug coverage, dental, vision and wellness programs, often with different cost-sharing structures compared to traditional Medicare.

A November report from Inovalon indicated MA beneficiaries generally experience improved health outcomes, encountering reduced avoidable hospitalizations, readmissions and lower rates of high-risk medication use.

The authors of the NEJM report question the affordability of a program that costs a minimum of 6% more per enrollee and scrutinized the insights offered by MA’s popularity concerning the limitations of traditional Medicare.

This growing expense, even prior to factoring in the effects of selective enrollment into MA, elevates federal expenditures, widens deficits and ultimately heightens costs for all beneficiaries.

The report cautioned the resultant fiscal strains exert pressure to curtail Medicare benefits and elevate federal taxes – both politically complex undertakings.

Furthermore, the escalating clout of the MA sector, accompanied by the substantial enrollment of older voters in these plans, presents political hurdles to significantly altering the program’s trajectory. The study also analyzed the implications of MA’s popularity on the constraints of traditional Medicare.

The allure of supplementary benefits and capped out-of-pocket expenses within MA designs has magnetized older and disabled Americans, while attempts to incorporate such services within traditional Medicare have met consistent failure due to explicit cost constraints.

The report notes the federal government indirectly shoulders these expenses through augmented payments to plans, and adds that the profits amassed by MA plans – which it says verge on being excessive – may not uniformly represent genuine efficiencies or enhanced value.

“Aside from these broad policy issues, some more-practical questions arise,” the study explained. “One concerns how the growth of Medicare Advantage will affect the ability of policymakers and researchers to understand and manage the Medicare program and the health system generally.”

The study suggests enhanced federal policies on risk adjustment, coding incentives, payment structures for quality and rectification of market imbalances in MA could improve evaluation of plan value for beneficiaries and taxpayers. It calls for ensuring accurate provider directories to mitigate misleading tactics.

“As Medicare Advantage continues to grow, federal authorities and plan stakeholders face a continuing challenge to craft a program that is affordable, high in quality, and free of abuse and that meets the needs of beneficiaries,” the report concludes.

THE LARGER TREND

A recent analysis of 1,300 hospitals revealed escalating reimbursement delays and shrinking cash reserves, highlighting the urgent need for interventions to ease financial strain and maintain consistent patient care.

The American Hospital Association has also urged the Centers for Medicare and Medicaid Services to address MA insurers that are disregarding CMS coverage rules.

The 2024 MA final rule ensures better alignment and coverage parity between traditional Medicare and MA, and increases oversight of Medicare Advantage Organizations (MAOs).

From -10.6% to 11.1%: 34 systems ranked by operating margins

Hospitals began 2023 with a median operating margin of -0.9%, but that figure has increased steadily month over month to hit 2% in November — the ninth consecutive month of positive margins. Despite a modest positive turning point for some hospitals and health systems this year, Fitch Ratings projects 2024 to be another “make or break” year for a significant portion of the sector.

Editor’s note: Operating margins are based on health systems’ most recent financial documents and vary by reporting periods, such as the three months ending Sept. 30, the nine months ending Sept. 30 and the 12 months ending Sept. 30.

1. Tenet Healthcare (Dallas)
*For the three months ending Sept 30

Revenue: $5.1 billion
Expenses: $4.99 billion
Operating income/loss: $568 million
Operating margin: 11.1%

2. HCA Healthcare (Nashville, Tenn.)
*For the three months ending Sept 30

Revenue: $16.21 billion
Expenses: $14.58 billion
Operating income/loss: $1.63 billion
Operating margin: 10.1%

3. Universal Health Services (King of Prussia, Pa.)
For the three months ending Sept. 30 

Revenue: $3.6 billion
Expenses: $3.3 billion
Operating income/loss: $285.4 million
Operating margin: 7.9%

4. Mayo Clinic (Rochester, Minn.)
*For the three months ending Sept 30

Revenue: $4.5 billion
Expenses: $4.2 billion 
Operating income/loss: $302 million
Operating margin: 6.7%

5. Stanford Health Care (Palo Alto, Calif.)
*For the 12 months ending Aug. 31

Revenue: $7.87 billion
Expenses: $7.46 billion
Operating income/loss: $414.9 million 
Operating margin: 5.3%

6. Community Health Systems (Franklin, Tenn.)
*For the three months ending Sept 30

Revenue: $3.09 billion
Expenses: $2.91 billion
Operating income/loss: $173 million
Operating margin: 5.6%

7. Christus Health (Irving, Texas) 
*For the 12 months ending June 30 

Revenue: $7.8 billion
Expenses: $7.5 billion
Operating income/loss: $324.5 million
Operating margin: 4.2%

8. Northwestern Medicine (Chicago) 
*For the 12 months ending Sept. 30

Revenue: $8.7 billion
Expenses: $8.4 billion
Operating income/loss: $352.3 million
Operating margin: 4.1%

9. IU Health (Indianapolis)
*For the three months ending Sept 30

Revenue: $2.12 billion
Expenses: $2.06 billion
Operating income/loss: $59.6 million
Operating margin: 2.8%

10. Sanford Health (Sioux Falls, S.D.)
*For the nine months ending Sept. 30

Revenue: $5.39 billion
Expenses: $5.27 billion
Operating income/loss: $123.2 million
Operating margin: 2.3%

11. BJC HealthCare (St. Louis)
*For the nine months ending Sept. 30

Revenue: $5.17 billion
Expenses: $5.06 billion
Operating income/loss: $113.2 million
Operating margin: 2.2%

12. Vanderbilt University Medical Center (Nashville, Tenn.)
*For the three months ending Sept 30

Revenue: $1.8 billion
Expenses: $1.77 billion
Operating income/loss: $28 million
Operating margin: 1.6%

13. Banner Health (Phoenix)
*For the nine months ending Sept. 30

Revenue: $10.3 billion
Expenses: $10.2 billion
Operating income/loss: $149.4 million
Operating margin: 1.5%

14. Intermountain Health (Salt Lake City)
*For the nine months ending Sept. 30

Revenue: $11.9 billion
Expenses: $11.2 billion
Operating income/loss: $157 million
Operating margin: 1.3%

15. Prisma Health (Greenville, S.C.)*For the 12 months ending Sept. 30

Revenue: $6 billion
Expenses: $5.9 billion
Operating income/loss: $67.1 million
Operating margin: 1.1%

16. Kaiser Permanente (Oakland, Calif.)
*For the three months ending Sept. 30 2023

Revenue: $24.9 billion
Expenses: $24.7 billion
Operating income/loss: $156 million
Operating margin: 0.6%

17. Advocate Health (Charlotte, N.C.)
*For the nine months ending Sept. 30

Revenue: $22.83 billion
Expenses: $22.75 billion
Operating income/loss: $79.4 million
Operating margin: 0.4%

18. Mercy (St. Louis-based)
*For the 12 months ending June 30 

Revenue: $8.02 billion
Expenses: $8.01 billion
Operating income/loss: $11.8 million
Operating margin: 0.1%

19. OSF HealthCare (Peoria, Ill.) 
*For the 12 months ending Sept. 30

Revenue: $4.1 billion
Expenses: $4.1 billion
Operating income/loss: $1.2 million
Operating margin: 0%

20. Northwell Health (New Hyde Park, N.Y.) 
*For the three months ending Sept. 30 

Revenue: $4.1 billion
Expenses: $4.2 billion
Operating income/loss: ($11.6 million)
Operating margin: (0.3%)

21. Mass General Brigham (Boston)
*For the 12 months ending Sept. 30

Revenue: $18.8 billion (includes $143 million revenue related to federal COVID-19 relief) 
Expenses: $18.7 billion
Operating income/loss: ($48 million)
Operating margin: (0.3% margin)

22. Cleveland Clinic
*For the three months ending Sept. 30 2023

Revenue: $3.6 billion
Expenses: $3.4 billion
Operating income/loss: ($14.9 million)
Operating margin: (0.4%)

23. Montefiore (New York City) 
*For the nine months ending Sept. 30

Revenue: $5.61 billion
Expenses: $5.64 billion
Operating income/loss: ($28.6 million)
Operating margin: (0.5%)

24. SSM Health (St. Louis)
*For the three months ending Sept 30

Revenue: $2.61 billion
Expenses: $2.63 billion
Operating income/loss: ($21.1 million) 
Operating margin: (0.8%)

25. UPMC (Pittsburgh)
*For the nine months ending Sept. 30

Revenue: $20.6 billion
Expenses: $20.8 billion
Operating income/loss: ($177 million)
Operating margin: (0.9%)

26. Scripps Health (San Diego) 
*For the 12 months ending Sept. 30

Revenue: $4.3 billion
Expenses: $4.3 billion
Operating income/loss: ($36.6 million)
Operating margin: (0.9%)

27. Trinity Health (Livona, Mich.) 
*For the three months ending Sept 30

Revenue: $5.6 billion
Expenses: $5.7 billion
Operating income/loss: ($58.6 million)
Operating margin: (1%)

28. UnityPoint Health (West Des Moines, Iowa)
*For the three months ending Sept 30

Revenue: $1.16 billion
Expenses: $1.18
Operating income/loss: ($16.4 million)
Operating margin: (1.4%)

29. Novant Health (Winston-Salem, N.C.) 
*For the three months ending Sept. 30

Revenue: $1.94 billion
Expenses: $1.97 billion
Operating income/loss: (28.6 million)
Operating margin: (1.5%)

30. Geisinger (Danville, Pa.)
*For the nine months ending Sept. 30

Revenue: $5.66 billion
Expenses: $5.76 billion
Operating income/loss: ($104.4 million)
Operating margin: (1.8%)

31. CommonSpirit (Chicago) 
*For the three months ending Sept. 30

Revenue: $8.58 billion
Expenses: $9.02 billion
*Adjusted operating income/loss: ($291 million)
Operating margin: (3.4%)

32. Tower Health (West Reading, Pa.)
*For the three months ending Sept. 30 

Revenue: $457.4 million
Expenses: $476.5 million
Operating income/loss: $19.1 million
Operating margin: (4.2%)

33. Providence (Renton, Wash.) 
*For the three months ending Sept. 30

Revenue: $7.18 billion
Expenses: $7.49 billion
Operating income/loss: ($310 million)
Operating margin: (4.3%)

34. Ascension (St. Louis)
*For the 12 months ending June 30 

Revenue: $28.35 billion
Expenses: $29.9 billion
Operating income/loss: ($3 billion)
Operating margin: (10.6%)